Novel modified method for injection into the cerebrospinal fluid via the cerebellomedullary cistern in mice

• Autorzy: Chen Y. , Imai H. , Ito A. , Saito N.
• Języki publikacji: EN

Abstrakty

EN

A modified method of injection into the cerebellomedullary (CM) cistern of mice was developed based on fixation of the mouse with a special mask under inhalation anesthesia, and exposure of the sagittal suture of the cranium and midline of the nape to allow us to visualize injection point directly. The accuracy of the modified method was evaluated using the temporal and spatial intracranial distribution of dye by intracisternal injection of methylene blue aqueous solution. A high concentration of dye was found in the CM cistern, the ventral cisterns, and intracranial proximal portion of the main cranial nerves at 1 hour after injection. The color of the dye in the CM cistern and the ventral cisterns was lighter, and the dye had reached the intracranial distal portion of the main cranial nerves at 6 hours after injection. The dye was completely eliminated by cerebrospinal fluid (CSF) circulation at 24 hours after injection. No severe brain injury was found in any of the 20 mice. Intracisternal injection was successful in all 14 mice sacrificed 1 hour or 6 hours after injection according to the confirmation of dye distribution. The effects of central administration of endothelin-1 (ET1) were evaluated on cerebral blood supply, constriction of cerebral arteries, and change of respiration in mice. Three doses of ET1 were studied: 2 ^g (0.8 nmol), 4 ^g (1.6 nmol), and 6 ^g (2.4 nmol). Cerebral blood flow (CBF) was monitored for 60 minutes following injection using a laser Doppler probe. Intracisternal ET1 injection induced dose-dependent reduction of CBF, constriction of cerebral arteries, and respiratory depression in mice. This modified method of injection into the CM cistern under direct visualization provides accurate and reproducible injection into the CSF, and can be used to investigate the effects of various chemical substances on the central nervous system in mice.

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2013
• Tom: 73
• Numer: 2
• Opis fizyczny: p.304-311,fig.,ref.

Twórcy

autor

Chen Y.

• Department of Neurosurgery, Faculty of Medicine, University of Tokyo, Tokyo, Japan
• Department of Neurosurgery, Sir Run Run Shaw Hospital, Medical College of Zhejiang University, Hongzhou, China

autor

Imai H.

• Department of Neurosurgery, Faculty of Medicine, University of Tokyo, Tokyo, Japan

autor

Ito A.

• Department of Neurosurgery, Faculty of Medicine, University of Tokyo, Tokyo, Japan

autor

Saito N.

• Department of Neurosurgery, Faculty of Medicine, University of Tokyo, Tokyo, Japan

Bibliografia

• Anderson PM, Sorenson MA (1994) Effects of route and formulation on clinical pharmacokinetics of interleukin-2. Clin Pharmacokinet 27: 19-31.
• Bai N, Moien-Afshari F, Washio H, Min A, Laher I (2004) Pharmacology of the mouse-isolated cerebral artery. Vascul Pharmacol 41: 97-106.
• Balerio GN, Rubio MC (2002) Baclofen analgesia: involve¬ment of the GABAergic system. Pharmacol Res 46: 281-286.
• Chan PH, Epstein CJ, Li Y, Huang TT, Carlson E, Kinouchi H, Yang G, Kamii H, Mikawa S, Kondo T (1995) Transgenic mice and knockout mutants in the study of oxidative stress in brain injury. J Neurotrauma 12: 815-824.
• Chen J, Zacharek A, Zhang C, Jiang H, Li Y, Roberts C, Lu M, Kapke A, Chopp M (2005) Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice. J Neurosci 25: 2366-2375.
• Chen Y, Ito A, Takai K, Saito N (2008) Blocking pterygo- palatine arterial blood flow decreases infarct volume vari¬ability in a mouse model of intraluminal suture middle cerebral artery occlusion. J Neurosci Methods 174: 18-24.
• Fuxe K, Cintra A, Andbjer B, Anggard E, Goldstein M, Agnati LF(1989) Centrally administered endothelin-1 produces lesions in the brain of the male rat. Acta Physiol Scand 137: 155-156.
• Grabow TS, Derdzinski D, Staats PS (2001) Spinal drug delivery. Curr Pain Headache Rep 5: 510-516.
• Horie N, Maag AL, Hamilton SA, Shichinohe H, Bliss TM, Steinberg GK (2008) Mouse model of focal cerebral isch¬emia using endothelin-1. J Neurosci Methods 173: 286¬290.
• Hughes PM, Anthony DC, Ruddin M, Botham MS, Rankine EL, Sablone M, Baumann D, Mir AK, Perry VH (2003) Focal lesions in the rat central nervous system induced by endothelin-1. J Neuropathol Exp Neurol 62: 1276¬1286.
• Ide K, Yamakawa K, Nakagomi T, Sasaki T, Saito I, Kurihara H, Yosizumi M, Yazaki Y, Takakura K (1989) The role of endothelin in the pathogenesis of vasospasm following subarachnoid haemorrhage. Neurol Res 11: 101-104.
• Johnson ND, Duysen EG, Lockridge O (2009) Intrathecal delivery of fluorescent labeled butyrylcholinesterase to the brains of butyrylcholinesterase knock-out mice: visu¬alization and quantification of enzyme distribution in the brain. Neurotoxicology 30: 386-392.
• Johnston M, Zakharov A, Koh L, Armstrong D (2005) Subarachnoid injection of Microfil reveals connections between cerebrospinal fluid and nasal lymphatics in the non¬human primate. Neuropathol Appl Neurobiol 31: 632-640.
• Koedel U, Bernatowicz A, Frei K, Fontana A, Pfister HW (1996) Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimen¬tal pneumococcal meningitis. J Immunol 157: 5185-5191.
• Li F, Hayashi T, Jin G, Deguchi K, Nagotani S, Nagano I, Shoji M, Chan PH, Abe K (2005) The protective effect of dantrolene on ischemic neuronal cell death is associated with reduced expression of endoplasmic reticulum stress markers. Brain Res 1048: 59-68.
• Macrae I, Robinson, M, McAuley M, Reid J, McCulloch J (1991) Effects of intracisternal endothelin-1 injection on blood flow to the lower brain stem. Eur J Pharmacol 203: 85-91.
• Macrae IM, Robinson MJ, Graham DI, Reid JL, McCulloch J (1993) Endothelin-1-induced reductions in cerebral blood flow: dose dependency, time course, and neuro- pathological consequences. J Cereb Blood Flow Metab 13: 276-284.
• Muehlschlegel S, Sims JR (2009) Dantrolene: mechanisms of neuroprotection and possible clinical applications in the neurointensive care unit. Neurocrit Care 10: 103-115.
• Nikolova S, Moyanova S, Hughes S, Bellyou-Camilleri M, Lee TY, Bartha R (2009) Endothelin-1 induced MCAO: dose dependency of cerebral blood flow. J Neurosci Methods 179: 22-28.
• Rainov NG, Kramm CM (2001) Vector delivery methods and targeting strategies for gene therapy of brain tumors. Curr Gene Ther 1: 367-383.
• Ro JY, Lee J, Capra NF, Zhang Y (2007) Role of soluble guanylate cyclase in the trigeminal subnucleus caudalis in capsaicin-induced muscle hypersensitivity. Brain Res 1184: 141-148.
• Robinson M, Macrae I, Todd M, Reid J, McCulloch J (1990) Reduction of local cerebral blood flow to pathological levels by endothelin-1 applied to the middle cerebral artery in the rat. Neurosci Lett 118: 269-272.
• Salomone S, Potts EM, Tyndall S, Ip PC, Chun J, Brinkmann V, Waeber C (2008) Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools. Br J Pharmacol 153: 140-147.
• Sharkey J, Butcher SP (1995) Characterisation of an experi¬mental model of stroke produced by intracerebral micro¬injection of endothelin-1 adjacent to the rat middle cere¬bral artery. J Neurosci Methods 60: 125-131.
• Shirao S, Fujisawa H, Kudo A, Kurokawa T, Yoneda H, Kunitsugu I, Ogasawara K, Soma M, Kobayashi S, Ogawa A, Suzuki M (2008) Inhibitory effects of eicosap- entaenoic acid on chronic cerebral vasospasm after suba- rachnoid hemorrhage: possible involvement of a sphingo- sylphosphorylcholine-rho-kinase pathway. Cerebrovasc Dis 26: 30-37.
• Tang BL (2008) Leptin as a neuroprotective agent. Biochem Biophys Res Commun 368: 181-185.
• Ueda H, Amano H, Shiomi H, Takagi H (1979) Comparison of the analgesic effects of various opioid peptides by a newly devised intracisternal injection technique in con¬scious mice. Eur J Pharmacol 56: 265-268.
• van der Flier M, Coenjaerts FE, Mwinzi PN, Rijkers E, Ruyken M, Scharringa J, Kimpen JL, Hoepelman AI, Geelen SP (2005) Antibody neutralization of vascular endothelial growth factor (VEGF) fails to attenuate vas¬cular permeability and brain edema in experimental pneu- mococcal meningitis. J Neuroimmunol 160: 170-177.
• Wang Y, Jin K, Greenberg DA (2007) Neurogenesis associ¬ated with endothelin-induced cortical infarction in the mouse. Brain Res 1167: 118-122.
• Windle V, Szymanska A, Granter-Button S, White C, Buist R, Peeling J, Corbett D (2006) Analysis of four different methods of producing focal cerebral ischemia with endothelin-1 in the rat. Exp Neurol 201: 324-334.

Uwagi

Rekord w opracowaniu